Crossmark

Molecular evidence reveals thyrotropin intervention enhances the risk of developing radioiodine-refractory differentiated thyroid carcinoma

Published Online: 2022-02-03

Published Print: 2022-12

Authors

Samimi, Hilda

Haghpanah, Vahid https://orcid.org/0000-0001-8337-0602
License Information

Text and Data Mining valid from 2022-02-03

Version of Record valid from 2022-02-03
More Information

Article History

Received: 23 September 2021

Accepted: 23 January 2022

First Online: 3 February 2022

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no conflict of interest.

Document is current